Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/14/2010US7851486 peripheral arterial occlusive disease (PAOD); prophylaxis of myocardial infarction by administering an agent that inhibits leukotriene synthesis in vivo for example (R)-(+)-alpha-cyclopentyl-4-(2-quinolinylmethoxy)-Benzeneacetic acid, BAY-X-1005
12/14/2010US7851485 Therapeutic agent for neuropathic pain
12/14/2010US7851484 Certain chemical entities, compositions, and methods
12/14/2010US7851483 Medicaments comprising steroids and a novel anticholinergic
12/14/2010US7851482 Method for making analgesics
12/14/2010US7851480 administering 2,4-pyrimidinediamine derivatives such as N4-[2-(2-Cyclopropyl)-3-oxo-4H-benz[1,4]oxazin-6-yl]-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine, for the treatment an autoimmune diseases, including rheumatoid arthritis, lupus, multiple sclerosis or anemia
12/14/2010US7851479 Use of pyrimidinedione derivative for preventing or treating hepatitis C
12/14/2010US7851478 Agent for preventing and/or treating movement disorder
12/14/2010US7851477 Eliminating redness; topical application of caffeine containing formulation; rosacea, folliculitis, irritation
12/14/2010US7851476 Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
12/14/2010US7851475 3-(1H-indol-3-yl)-4-[5-(4-methyl-piperazin-1-yl)-2-nitro-phenyl]-pyrrole-2,5-dione, useful in the treatment of transplant rejection, graft versus host diseases, restenosis, obesity, syndrome X, diabetes, polycystic ovary syndrome, hypertension, cardiovascular or respiratory system disorders
12/14/2010US7851474 Dipiperazinyl ketones and related analogues
12/14/2010US7851473 fatty acid amide hydrolase inhibitors such as N-(2-Chlorophenyl)-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide, used for the prophylaxis of brain, psychological or sleep disorders, as neuroprotectants, analgesics, antidepressants or anxiolytic agents
12/14/2010US7851472 Cyclopropanecarboxylic acid {4-[3-(4-methoxy-phenyl)-[1,2,4]triazolo[3,4-a]phthalazin-6-ylamino]-phenyl}-amide; phosphodiesterase inhibitors; neoangiogenesis or inflammatory disease
12/14/2010US7851471 Compounds I
12/14/2010US7851470 Substantially pure N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide salts, solvates, hydrates, prodrugs; hyperproliferative disorders, cancers, pre-cancers, osteoporosis, cardiovascular disorders; bacterial, fungal, parasitic or viral infection
12/14/2010US7851469 Isoxazole-imidazole derivatives
12/14/2010US7851468 Substituted pyrazolo[3,4-d]pyrimidines
12/14/2010US7851467 Carbamate compounds as 5-HT4 receptor agonists
12/14/2010US7851466 administering pyrimidine derivatives such as N-(1H-indol-3-ylmethylene)-N'-{6-morpholin-4-yl-2-[2-(pyridin-3-yloxy)-ethoxy]-pyrimidin-4-yl}-hydrazine, to inhibit the production of interleukins, useful for treating autoimmune and inflammatory disorders
12/14/2010US7851465 Benzodiazepine compounds; controlling cell death, autoimmune diseases; antiinflammatory agents; antiproliferative agents; antiarthritic agents; multiple sclerosis;Crohn's disease; leukemia; inflammatory bowel disorders; anticancer, antitumor agents; asthma; psoriasis
12/14/2010US7851464 Spirolactam aryl CGRP receptor antagonists
12/14/2010US7851463 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide
12/14/2010US7851462 Methods and compositions for inhibiting tumor growth
12/14/2010US7851461 Combination dosage of a cyclooxygenase (COX) inhibitor, a vitamin D3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer
12/14/2010US7851460 such as 7-(2,4-difluorophenyl)sancycline, used for the treatment of bacterial infections in mammals
12/14/2010US7851458 Cartilage enhancing food supplements and methods of preparing the same
12/14/2010US7851457 antianthrax agent; low molecular weight derivataive of cyclodextrin with seven D-glucose units, that block the pore formed by protective antigen and inhibit anthrax toxin action
12/14/2010US7851456 P2Y6 receptor agonists for treating lung diseases
12/14/2010US7851454 Short immunomodulatory oligonucleotides
12/14/2010US7851453 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
12/14/2010US7851452 Methods of use of bcl-6-derived nucleotides to induce apoptosis
12/14/2010US7851451 Formulations for mediating inflammatory bowel disorders
12/14/2010US7851450 Gangliosides with a modified acyl function
12/14/2010US7851439 useful in interfering with the life cycle of bacteria and in treating or preventing a bacterial infection
12/14/2010US7851438 PEGylated with desired N-glycoforms; ease of administration; pharmacokinetics, bioavailability; lower cost biosynthesis technique utilizing lower eukaryotic cells
12/14/2010US7851214 Myxoviral vector as somatic gene therapeutic tool; genetic vaccines; tissue targeted therapy; antitumor agents
12/14/2010US7851183 Nucleotide sequences coding modified polyketide synthase for use in development of pharmaceutical, agricultural and/or veterinary products
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7850996 Therapy, prevention of papillomavirus infections; antiinflammatory agents; wound healing agents
12/14/2010US7850995 having a cationic surfactant adsorbed on their surfaces to provide superior adhesion to a biological substrate, e.g., an insect, teeth, bone, nails, chitin, feathers, plants, mucous, skin; drug delivery
12/14/2010US7850991 Calcium formate for use as a dietary supplement
12/14/2010US7850990 Compositions for delivery of drug combinations
12/14/2010US7850989 Critical care for neonatal calves
12/14/2010US7850984 Administering antagonist to sphingomyelinase gene product;side effect reduction of cancer therapy
12/14/2010US7850980 Chlamydia OMP antigen
12/14/2010US7850975 Chemically programmable immunity
12/14/2010US7850971 PSMA antibodies and protein multimers
12/14/2010US7850970 Bacrtericides; viricides; administering antitrypsin; gramnedative, grampositive bacteria; anthrax
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850959 Methods and compositions for treating conditions involving abnormal angiogenesis
12/14/2010US7850955 contain a specific N-acylamino acid monoamide monoalkyl ester; do not cause sweating while retaining a practical level of gel strength; good spreadability, and good fittability to skin; antiperspirants
12/14/2010US7850676 System with a reservoir for perfusion management
12/14/2010US7850008 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/14/2010CA2715662A1 Phenylpropanoid diglycerides for the treatment of cancer
12/14/2010CA2624847C Dermatitis treating agent
12/14/2010CA2591867C Cooling topical patch preparation
12/14/2010CA2575718C Salts of benzimidazole derivative with amines and process for manufacturing the same
12/14/2010CA2575512C Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
12/14/2010CA2561374C Process for producing folic acid derivatives
12/14/2010CA2558026C Hiv integrase inhibitors
12/14/2010CA2535199C Amide derivative
12/14/2010CA2515343C Antiparasitic terpene alkaloids
12/14/2010CA2504755C Carbohydrate-based synthetic vaccines for hiv
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2485424C Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
12/14/2010CA2478811C Tasted masked veterinary solid compositions
12/14/2010CA2473228C Sunscreen compositions as well as dihydropyridines and dihydropyranes
12/14/2010CA2470480C Indolinone derivatives useful as protein kinase inhibitors
12/14/2010CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
12/14/2010CA2462376C Liposome loading with metal ions
12/14/2010CA2461890C Water soluble nanoparticles of hydrophilic and hydrophobic active materials
12/14/2010CA2459472C Sustained release micropellets and process for producing the same
12/14/2010CA2458524C C2-disubstituted indane-1-ones and their derivatives, method for their production and their use as medicaments
12/14/2010CA2458520C Polysubstituted indan-1-ol systems, method for the production and use thereof as drugs
12/14/2010CA2456531C Process for the preparation of 4-(imidazole-1-yl)benzenesulfonamide derivatives
12/14/2010CA2449769C S-omeprazole (esomeprazole) inclusion complex with cyclodextrins
12/14/2010CA2447525C Pharmaceutical and cosmetic compositions against skin aging
12/14/2010CA2446673C Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
12/14/2010CA2444870C Skin-protective compositions effective against vesicants and percutaneous chemical agents
12/14/2010CA2438339C Use of buprenorphine for treatment of urinary incontinence
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2433858C Purine derivatives as purinergic receptor antagonists
12/14/2010CA2430909C Inhibitors of papilloma virus
12/14/2010CA2420292C Contraception process and administration form for the same
12/14/2010CA2417484C Elongase genes and uses thereof
12/14/2010CA2414787C Coumarin derivatives with comt inhibiting activity
12/14/2010CA2412723C Benzothiazolyl ppar-gamma modulators
12/14/2010CA2400737C Nutritional formulation containing prebiotic substances
12/14/2010CA2400124C Tnf-.alpha. inhibitors
12/14/2010CA2391274C Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
12/14/2010CA2373433C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
12/14/2010CA2366857C Phthalazine derivatives for treating inflammatory diseases
12/14/2010CA2365392C Vaccine preparation containing fatty acid as a constituent
12/14/2010CA2355939C Antihistaminic spiro compounds
12/14/2010CA2347100C Novel indenoisoquinolines as antineoplastic agents
12/14/2010CA2336781C Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics
12/14/2010CA2326764C Acylbenzoxazines for enhancing synaptic response(s)
12/14/2010CA2308116C Low-toxicity human interferon-alpha analog
12/14/2010CA2295930C Pharmaceutical compositions having cholesterol-lowering effect
1 ... 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 ... 7860